---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-004055"
form_type: "8-K/A"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:52:33.108664+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Windtree converts Series C Preferred to common at $0.1608, issuers 11.8M shares; holders grant forbearance.

## Summary
- Approximately 1,895 Series C Preferred shares converted into 11,792,305 common shares at reduced conversion price of $0.1608.
- Holders agreed to forbearance on claims under securities purchase agreements and warrants through April 30, 2025.
- Exercise price of related warrants also reduced to $0.1608 effective January 24, 2025.
- Conversion was effected via a Conversion Notice signed by holders by Jan 31, 2025; exempt from registration under Section 3(a)(9) and 4(a)(2).
- Company had previously registered up to 27,668,106 shares for resale on Form S-3 effective Sep 3, 2024.

## SEC filing metadata
- accession: 0001437749-25-004055
- form_type: 8-K/A
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774925004055/0001437749-25-004055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774925004055/wint20250214_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-004055
- JSON: https://secwatch.observer/filing/0001437749-25-004055.json
- Plain text: https://secwatch.observer/filing/0001437749-25-004055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.